tiprankstipranks
ImmunoPrecise Antibodies (TSE:IPA)
TSXV:IPA

ImmunoPrecise Antibodies (IPA) Balance Sheet

23 Followers

ImmunoPrecise Antibodies Balance Sheet

ImmunoPrecise Antibodies's total assets for Q4 2023 were C$77.81M, a decrease of -5.61% from the previous quarter. TSE:IPA total liabilities were C$20.01M for the fiscal quarter, a -6.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Apr 23Apr 22Apr 21Apr 20Apr 19
Total Assets
C$ 77.81MC$ 93.49MC$ 66.96MC$ 27.26MC$ 28.46M
Total Liabilities
C$ 20.01MC$ 18.21MC$ 10.04MC$ 12.18MC$ 10.39M
Total Equity Gross Minority
C$ 57.80MC$ 75.28MC$ 56.92MC$ 15.09MC$ 18.07M
Total Capitalization
C$ 57.80MC$ 75.28MC$ 58.45MC$ 15.59MC$ 18.10M
Preferred Stock Equity
-----
Capital Lease Obligations
--C$ 1.93MC$ 1.88MC$ 107.08K
Currency in CAD

ImmunoPrecise Antibodies Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis